4D Molecular Therapeutics
FDMT
#7172
Rank
โ‚ฌ0.52 B
Marketcap
9,33ย โ‚ฌ
Share price
-4.57%
Change (1 day)
-0.92%
Change (1 year)

EPS for 4D Molecular Therapeutics (FDMT)

EPS in 2026 (TTM): -3,48ย โ‚ฌ

According to 4D Molecular Therapeutics's latest financial reports the company's current EPS (TTM) is -3,68ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,21ย โ‚ฌ an increase over its 2024 EPS that were of -2,72ย โ‚ฌ.

EPS history for 4D Molecular Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-3,48ย โ‚ฌ57.56%
2025-2,21ย โ‚ฌ-18.79%
2024-2,72ย โ‚ฌ15.5%
2023-2,35ย โ‚ฌ-22.29%
2022-3,03ย โ‚ฌ29.18%
2021-2,34ย โ‚ฌ-70.86%
2020-8,04ย โ‚ฌ165.38%
2019-3,03ย โ‚ฌ335.61%
2018-0,70ย โ‚ฌ0.85%
2017-0,69ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ-66.58%๐Ÿ‡บ๐Ÿ‡ธ USA